It is now believed that METTL3 regulates the metabolic reprogramming of tumors by modulating the expression of glucose transporters (GLUTs), lactate dehydrogenase (LDHA) and enolase 1 (ENO1) in tumor cells (Fig. 5). This evidence concerns the gene METTL3 and neoplasm.